Titles

Associate Professor of Practice, Sciences, and Health Outcomes Research

School Affiliation

School of Pharmacy

Specialties

• Medication Adherence and Decision-Analytic Modeling
• Cost Effectiveness and Comparative Effectiveness Research

About

410-706-5397 jslejko@rx.umaryland.edu

Dr. Slejko’s research is focused on innovative approaches for decision-analytic modeling for economic and health outcomes assessments. She has applied these methods to modeling medication adherence and translating pharmacometric findings to cost-effectiveness analyses. She holds a BA in Molecular, Cellular and Developmental Biology from the University of Colorado Boulder. Her PhD training at the University of Colorado School of Pharmacy Center for Pharmaceutical Outcomes Research was focused on pharmacoeconomics. Her postdoctoral training was completed at the Pharmaceutical Outcomes Research and Policy Program in the University of Washington School of Pharmacy. Prior to her PhD training, she had a seven-year career in drug discovery at Array BioPharma. Dr. Slejko is very active in the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and maintains close connections with industry and academic partners. Her research focuses on assessing economic and comparative value of medications and health care. Current efforts include informing decision-analytic models with real-world evidence on effectiveness, in particular patients’ adherence to medications as a determinant of value, how adherence affects economic evaluations and how predicting and improving adherence may increase value. As co-director of the School of Pharmacy's Patient-Driven Values in Healthcare Evaluation (PAVE) Center, she leads research on incorporating patient-driven value elements into cost-effectiveness analyses and other components of value assessments.

Read a longer bio.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged: The Future of Health Care   Ensuring Access and Equity in Health Care   Research and Innovation  

This information was last updated May 17, 2023.